Conatus Announces Completion of Enrollment in ENCORE-LF Phase 2b Clinical Trial of Emricasan Pharmaceutical Investing
Fortress Biotech Completes Final Stage Closing of the Sale of its Remaining Shares of National Holdings Biotech Investing
Isodiol International Inc. Sharpens Strategy for Growth, Profitability, and Increases in Shareholder Value Biotech Investing
Cannara: A Vertically-Integrated Cannabis Company in the Making; Leveraging Quebec’s Market Cannabis Investing News
MediPharm Labs Signs $35 Million Private Label Cannabis Oil Sale Agreement with Option for Additional $13.5 Million Cannabis Investing News
